Ongoing treatment(s)-Bone marrow transplant Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Bone marrow transplant Posts on Medivizor

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Posted by on Jun 21, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to compare outcomes of allogeneic hematopoietic stem cell transplant (alloHSCT) using cryopreserved (frozen) and fresh grafts in patients with blood cancers who received post-transplant cyclophosphamide (Cytoxan). This study concluded that cryopreservation (CP) does not affect the outcomes of HSCT in these patients....

Read More

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Posted by on Jun 21, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to compare outcomes of allogeneic hematopoietic stem cell transplant (alloHSCT) using cryopreserved (frozen) and fresh grafts in patients with blood cancers who received post-transplant cyclophosphamide (Cytoxan). This study concluded that cryopreservation (CP) does not affect the outcomes of HSCT in these patients....

Read More

Higher or lower radiotherapy dose for patients with non-Hodgkin lymphoma undergoing stem cell transplantation?

Higher or lower radiotherapy dose for patients with non-Hodgkin lymphoma undergoing stem cell transplantation?

Posted by on May 26, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined how effective and safe a higher radiotherapy dose was for patients with non-Hodgkin lymphoma (NHL) undergoing stem cell transplantation (SCT). The authors found that patients who received a lower radiotherapy dose survived longer and had fewer side effects than the higher dose. Some background NHL is a cancer of...

Read More

Evaluating cyclophosphamide in patients with acute myeloid leukemia receiving donor transplants

Evaluating cyclophosphamide in patients with acute myeloid leukemia receiving donor transplants

Posted by on May 24, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate post-transplant cyclophosphamide treatment in patients with acute myeloid leukemia. This study concluded that this treatment is safe and effective in these patients.   Some background Post-transplant cyclophosphamide (PTCy) is an immune system suppressant. It can be used after...

Read More

Do stem cell transplants improve patients’ long-term survival?

Posted by on Apr 25, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such as...

Read More

Do stem cell transplants improve patients’ long-term survival?

Posted by on Apr 25, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such as...

Read More

How effective and safe is high-dose chemotherapy and stem cell transplant for children with lymphoma?

Posted by on Apr 14, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of high-dose chemotherapy and stem cell transplants for children with lymphoma. The study showed that the combination treatment was very effective but that the dose may need to be adjusted for some patients. Some background Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) have very...

Read More

Long-term outcomes for acute myeloid leukemia patients treated with reduced intensity conditioning and hematopoietic stem cell transplant

Posted by on Apr 10, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the long-term outcomes for patients with acute myeloid leukemia who received reduced-intensity conditioning and allogeneic stem cell transplant.  This study concluded that this treatment is safe and effective in these patients in the long-term.   Some background One of the standard...

Read More

Outcomes for patients with acute myeloid leukemia who receive ex vivo T cell-depleted hematopoietic stem cell transplantation

Posted by on Nov 24, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of patients with acute myeloid leukemia after ex vivo T cell-depleted allogeneic hemopoietic stem cell transplant.   This study concluded that the outcomes for these patients compare favorably to an unmodified transplant and that the modified transplant leads to lower rates of...

Read More

Testosterone levels in male patients with acute myeloid leukemia undergoing stem cell transplantation

Posted by on Jul 31, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the impact of testosterone levels before a stem cell transplantation (SCT) on outcomes in male patients with acute myeloid leukemia (AML).    This study concluded that testosterone levels may predict the outcomes of these patients.  Some background Testosterone is a male...

Read More

Busulfan and fludarabine before transplant in the treatment of older patients with acute myeloid leukemia

Posted by on Jul 14, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effectiveness of busulfan (Busilvex) and fludarabine (Fludara) before transplant in the treatment of older patients with acute myeloid leukemia (AML). Researchers found that this treatment was safe and effective in these patients. Some background Acute myeloid leukemia is a cancer of the bone marrow. It...

Read More